Most cited papers from Zogenix (United States)

Zogenix (United States)

What are the most cited papers from Zogenix (United States)?

The most cited paper from Zogenix (United States) is "Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial" (Lieven G. Lagae, Joseph E. Sullivan, Kelly G. Knupp et al., 2019), with 381 citations. Next come "Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens" (251) and "Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome" (136).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 59 papers. Every paper with more than 10 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial Lieven G. Lagae, Joseph E. Sullivan, Kelly G. Knupp et al. · The Lancet Open access	Dec 2019	381
2	Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens Rima Nabbout, Arun Mistry, Sameer M. Zuberi et al. · JAMA Neurology Open access	2 Dec 2019	251
3	Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome Kelly G. Knupp, Ingrid Eileen Scheffer, Berten Ceulemans et al. · JAMA Neurology Open access	2 May 2022	136
4	Bioinspired Design Provides High‐Strength Benzoxazine Structural Adhesives Cody James Higginson, Katerina G. Malollari, Yunqi Xu et al. · Angewandte Chemie International Edition Open access	5 Jul 2019	134
5	Low‐dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients An‐Sofie Schoonjans, Bernard P. Paelinck, Fabienne Marchau et al. · European Journal of Neurology Open access	28 Oct 2016	107
6	Fenfluramine acts as a positive modulator of sigma-1 receptors Parthena Martin, Peter A.M. de Witte, Tangui Maurice et al. · Epilepsy & Behavior Open access	10 Mar 2020	99
7	Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome Judith Helen Cross, Bradley S. Galer, António Gil‐Nagel et al. · Seizure Open access	2 Nov 2021	85
8	A pilot, open‐label study of the effectiveness and tolerability of low‐dose ZX 008 (fenfluramine HC l) in Lennox‐Gastaut syndrome Lieven G. Lagae, An‐Sofie Schoonjans, Arnold R. Gammaitoni et al. · Epilepsia Open access	26 Aug 2018	71
9	Life impact of caregiving for severe childhood epilepsy: Results of expert panels and caregiver focus groups Mark P. Jensen, Kendra S. Liljenquist, Fraser D. Bocell et al. · Epilepsy & Behavior	20 Jul 2017	71
10	Fenfluramine HCl (Fintepla®) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study Joseph E. Sullivan, Ingrid Eileen Scheffer, Lieven G. Lagae et al. · Epilepsia Open access	19 Oct 2020	69
11	Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver survey Jonathan D. Campbell, Melanie D. Whittington, Chong Kim et al. · Epilepsy & Behavior Open access	2 Feb 2018	68
12	Porting the synthetic D‐glucaric acid pathway from Escherichia coli to Saccharomyces cerevisiae Amita Gupta, Michael A. Hicks, Shawn P. Manchester et al. · Biotechnology Journal Open access	17 Jun 2016	68
13	A randomized controlled trial of ganaxolone in posttraumatic stress disorder Ann M. Rasmusson, Christine E. Marx, Sonia Jain et al. · Psychopharmacology	30 Jun 2017	67
14	A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiripentol, clobazam, and valproate in healthy subjects Brooks Boyd, Steven M. Smith, Arnold R. Gammaitoni et al. · International Journal of Clinical Pharmacology and Therapeutics Open access	19 Oct 2018	64
15	Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet syndrome Kim I. Bishop, Peter K. Isquith, Gérard A. Gioia et al. · Epilepsy & Behavior Open access	20 May 2021	61
16	The humanistic and economic burden of Dravet syndrome on caregivers and families: Implications for future research Mark P. Jensen, Andreas Brunklaus, Liam Dorris et al. · Epilepsy & Behavior	18 Apr 2017	60
17	An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies Parthena Martin, Thadd Reeder, Jo Sourbron et al. · International Journal of Molecular Sciences Open access	5 Aug 2021	55
18	convertibleCARs: A chimeric antigen receptor system for flexible control of activity and antigen targeting Kyle E. Landgraf, Steven R. Williams, Daniel Steiger et al. · Communications Biology Open access	9 Jun 2020	54
19	Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study Kelly G. Knupp, Ingrid Eileen Scheffer, Berten Ceulemans et al. · Epilepsia Open access	5 Oct 2022	53
20	Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo‐controlled clinical trial Joseph E. Sullivan, Lieven G. Lagae, Judith Helen Cross et al. · Epilepsia Open access	6 Aug 2023	52
21	Single-Entity Hydrocodone Extended-Release Capsules in Opioid-Tolerant Subjects with Moderate-to-Severe Chronic Low Back Pain: A Randomized Double-Blind, Placebo-Controlled Study Richard L Rauck, Srinivas R. Nalamachu, James E. Wild et al. · Pain Medicine	12 Feb 2014	52
22	Bidirectional C and N transfer and a potential role for sulfur in an epiphytic diazotrophic mutualism Rhona K. Stuart, Eric R. A. Pederson, Philip D. Weyman et al. · The ISME Journal Open access	19 Aug 2020	48
23	Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long‐term open‐label safety extension study Wyman W. Lai, Bradley S. Galer, Pierre C. Wong et al. · Epilepsia Open access	18 Aug 2020	48
24	Needle‐Free Subcutaneous Sumatriptan (Sumavel™ DosePro™): Bioequivalence and Ease of Use Jan Lewis Brandes, Roger K. Cady, Fred G. Freitag et al. · Headache The Journal of Head and Face Pain	22 Oct 2009	47
25	An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real‐world practice setting: A report from the Fenfluramine European Early Access Program Renzo Guerrini, Nicola Specchio, Ángel Aledo‐Serrano et al. · Epilepsia Open Open access	8 Jul 2022	45
26	Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopment Kim I. Bishop, Peter K. Isquith, Gérard A. Gioia et al. · Epilepsy & Behavior Open access	Dec 2022	44
27	The direct and indirect costs of Dravet Syndrome Melanie D. Whittington, Kelly G. Knupp, Gina R. VanderVeen et al. · Epilepsy & Behavior	2 Feb 2018	44
28	Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient population An‐Sofie Schoonjans, Fabienne Marchau, Bernard P. Paelinck et al. · Current Medical Research and Opinion Open access	13 Jul 2017	44
29	Communicating Structure and Function in Synthetic Biology Diagrams Jacob Beal et al. · ACS Synthetic Biology Open access	26 Jul 2019	43
30	A Mechanistic Study of Polyol Hydrodeoxygenation over a Bifunctional Pt-WOx/TiO2 Catalyst Kyle J. Stephens, Alan M. Allgeier, Alysha L. Bell et al. · ACS Catalysis	23 Oct 2020	42
31	Synthetic Biology Open Language (SBOL) Version 2.3 Curtis Madsen et al. · Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics Open access	13 Jun 2019	39
32	Fenfluramine significantly reduces day‐to‐day seizure burden by increasing number of seizure‐free days and time between seizures in patients with Dravet syndrome: A time‐to‐event analysis Joseph E. Sullivan, Nicola Specchio, Orrin Devinsky et al. · Epilepsia Open access	22 Oct 2021	38
33	Collaborating constructively for sustainable biotechnology Nicholas E. Matthews, Carrie A. Cizauskas, Donovan S. Layton et al. · Scientific Reports Open access	13 Dec 2019	38
34	Long-term cardiovascular safety of fenfluramine in patients with Dravet syndrome treated for up to 3 years: Findings from serial echocardiographic assessments Anupam Agarwal, Gail M. Farfel, Arnold R. Gammaitoni et al. · European Journal of Paediatric Neurology Open access	24 May 2022	30
35	Catalyzed reaction of isocyanates (RNCO) with water Mark E. Wolf, Jonathon E. Vandezande, Henry F. Schaefer · Physical Chemistry Chemical Physics	2021	30
36	Fenfluramine treatment for dravet syndrome: Real-world benefits on quality of life from the caregiver perspective Mark P. Jensen, Arnold R. Gammaitoni, Bradley S. Galer et al. · Epilepsy Research	7 Jul 2022	29
37	In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions Parthena Martin, Maciej Czerwiński, Pallavi B. Limaye et al. · Pharmacology Research & Perspectives Open access	22 May 2022	23
38	In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions Parthena Martin, Maciej Czerwiński, Pallavi B. Limaye et al. · Pharmacology Research & Perspectives Open access	22 May 2022	22
39	Psychosocial impact on siblings of patients with developmental and epileptic encephalopathies Laurie Bailey, Lauren Schwartz, Tracy Dixon‐Salazar et al. · Epilepsy & Behavior Open access	22 Aug 2020	22
40	Fenfluramine treatment for Dravet syndrome: Caregiver- and clinician-reported benefits on the quality of life of patients, caregivers, and families living in Germany, Spain, Italy, and the United Kingdom Mark P. Jensen, Arnold R. Gammaitoni, Rana Salem et al. · Epilepsy Research Open access	15 Jan 2023	21
41	Synthetic Biology Open Language Visual (SBOL Visual) Version 2.1 Curtis Madsen et al. · Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics Open access	13 Jun 2019	21
42	Satisfaction With and Confidence in Needle‐Free Subcutaneous Sumatriptan in Patients Currently Treated with Triptans Roger K. Cady, Sheena K. Aurora, Jan Lewis Brandes et al. · Headache The Journal of Head and Face Pain	3 Aug 2011	21
43	Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growth António Gil‐Nagel, Joseph E. Sullivan, Berten Ceulemans et al. · Epilepsy & Behavior Open access	2 Aug 2021	19
44	The Lack of Effect of Food on the Pharmacokinetics of ZX008 (Fenfluramine Oral Solution): Results of a Single-dose, Two-period Crossover Study Arnold R. Gammaitoni, Steven M. Smith, Brooks Boyd · Clinical Therapeutics Open access	22 Jun 2018	18
45	A real‐world study to assess the association of cardiovascular adverse events (CVAEs) with ibrutinib as first‐line (1L) treatment for patients with chronic lymphocytic leukaemia (CLL) in the United States Anthony R. Mato, Boxiong Tang, Soraya Azmi et al. · eJHaem Open access	23 Jan 2023	16
46	Fenfluramine modulates the anti-amnesic effects induced by sigma-1 receptor agonists and neuro(active)steroids in vivo Parthena Martin, Tangui Maurice, Arnold R. Gammaitoni et al. · Epilepsy & Behavior Open access	7 Jan 2022	16
47	A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain Srinivas R. Nalamachu, Richard L Rauck, Martin E Hale et al. · Journal of Pain Research Open access	Nov 2014	16
48	The impact of TK2 deficiency syndrome and its treatment by nucleoside therapy on quality of life Dagmar Amtmann, Arnold R. Gammaitoni, Bradley S. Galer et al. · Mitochondrion	29 Oct 2022	15
49	Development and validation of the University of Washington caregiver stress and benefit scales for caregivers of children with or without serious health conditions Dagmar Amtmann, Kendra S. Liljenquist, Alyssa M. Bamer et al. · Quality of Life Research	4 Jan 2020	15
50	Influence of Sulfur‐Containing Diamino Acid Structure on Covalently Crosslinked Copolypeptide Hydrogels Eric D. Raftery, Eric G. Gharkhanian, Nicole G. Ricapito et al. · Chemistry - An Asian Journal Open access	17 Sep 2018	14

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.